Markets & Regulations

Rhodia CEO quits

Rhodia CEO quits

Troubled chemicals group Rhodia sees its CEO depart as the company
announces another restructuring round that will see €600m in
divestments by end-2004.

Pan rescue bid fails

Pan rescue bid fails

The creditors of Australian over-the-counter medicines and vitamins
manufacturer Pan Pharmaceuticals have rejected a rescue bid for the
company at a meeting held last week. Another meeting is due to be
held later today.

Animal groups bomb Chiron HQ

Animal groups bomb Chiron HQ

Chiron's headquarters is hit by two homemade bombs, with an animal
rights group claiming responsibility. The blasts caused no
casualties and only minor damage to property, but represent an
alarming escalation in the tactics used...

Focus shift for Fugensoft

Focus shift for Fugensoft

US e-business software company Fugensoft has revamped its product
range, introducing a suite of new products and a change of focus,
to meet the needs of the biotech and pharmaceutical industry 'where
there is a huge need for...

Follow us

Products

View more

Webinars